|
|
Article: Par Pharmaceutical Announces Product Collaboration with Spectrum Pharmaceuticals, Inc.
- Article from:
- PR Newswire
- Article date:
- February 23, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Par Gains Access to Several Generic Injectable and Ophthalmic Products Currently Awaiting FDA Approval, Including Potential First-to-File Sumatriptan Injection
SPRING VALLEY, N.Y., Feb. 23 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. today announced that it has entered into a collaborative agreement with Spectrum Pharmaceuticals, Inc. to develop and market generic drugs, including generic versions of injectable and ophthalmic pharmaceuticals. Spectrum, located in Irvine, California, is a specialty pharmaceutical company that develops both proprietary and generic drugs.
"Our collaboration with Spectrum will expand the therapeutic ...